Interaction of Postoperative Morbidity and Receipt of Adjuvant Therapy on Long-Term Survival After Resection for Gastric Adenocarcinoma: Results From the US Gastric Cancer Collaborative

被引:68
作者
Jin, Linda X. [1 ,2 ]
Sanford, Dominic E. [1 ,2 ]
Squires, Malcolm Hart, III [3 ]
Moses, Lindsey E. [1 ,2 ]
Yan, Yan [1 ,2 ]
Poultsides, George A. [4 ]
Votanopoulos, Konstantinos I. [5 ]
Weber, Sharon M. [6 ]
Bloomston, Mark [7 ]
Pawlik, Timothy M. [8 ]
Hawkins, William G. [1 ,2 ]
Linehan, David C. [1 ,2 ]
Schmidt, Carl [7 ]
Worhunsky, David J. [4 ]
Acher, Alexandra W. [6 ]
Cardona, Kenneth [3 ]
Cho, Clifford S. [6 ]
Kooby, David A. [3 ]
Levine, Edward A. [5 ]
Winslow, Emily [6 ]
Saunders, Neil [7 ]
Spolverato, Gaya [8 ]
Colditz, Graham A. [1 ,2 ]
Maithel, Shishir K. [3 ]
Fields, Ryan C. [1 ,2 ]
机构
[1] Washington Univ, Sch Med, Dept Surg, Barnes Jewish Hosp, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO 63130 USA
[3] Emory Univ, Winship Canc Inst, Dept Surg, Div Surg Oncol, Atlanta, GA 30322 USA
[4] Stanford Univ, Med Ctr, Dept Surg, Stanford, CA 94305 USA
[5] Wake Forest Univ, Dept Surg, Winston Salem, NC 27109 USA
[6] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA
[7] Ohio State Univ, Ctr Comprehens Canc, Dept Surg, Columbus, OH 43210 USA
[8] Johns Hopkins Univ, Sch Med, Div Surg Oncol, Baltimore, MD USA
关键词
NEOADJUVANT CHEMOTHERAPY; CURATIVE RESECTION; RISK-FACTORS; COMPLICATIONS; SURGERY; IMPACT; OUTCOMES; D2; LYMPHADENECTOMY; GASTRECTOMY;
D O I
10.1245/s10434-016-5121-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Postoperative complications (POCs) can negatively impact survival after oncologic resection. POCs may also decrease the rate of adjuvant therapy completion. We evaluated the impact of complications on gastric cancer survival and analyzed the combined effect of complications and adjuvant therapy on survival. We analyzed 824 patients from 7 institutions of the U.S. Gastric Cancer Collaborative who underwent curative resection for gastric adenocarcinoma between 2000 and 2012. POC were graded using the modified Clavien-Dindo system. Survival probabilities were estimated using the method of Kaplan and Meier and analyzed using multivariate Cox regression. Median follow-up was 35 months. The overall complication rate was 41 %. The 5-year overall survival (OS) and recurrence-free survival (RFS) of patients who experienced complications were 27 and 23 %, respectively, compared with 43 and 40 % in patients who did not have complications (p < 0.0001 for OS and RFS). On multivariate analysis, POC remained an independent predictor for decreased OS and RFS (HR 1.3, 95 % CI 1.1-1.6, p = 0.03 for OS; HR 1.3, 95 % CI 1.01-1.6, p = 0.03 for RFS). Patients who experienced POC were less likely to receive adjuvant therapy (OR 0.5, 95 % CI 0.3-0.7, p < 0.001). The interaction of complications and failure to receive adjuvant therapy significantly increased the hazard of death compared with patients who had neither complications nor adjuvant therapy (HR 2.3, 95 % CI 1.6-3.2, p < 0.001). Postoperative complications adversely affect long-term outcomes after gastrectomy for gastric cancer. Not receiving adjuvant therapy in the face of POC portends an especially poor prognosis following gastrectomy for gastric cancer.
引用
收藏
页码:2398 / 2408
页数:11
相关论文
共 33 条
  • [1] RISING INCIDENCE OF ADENOCARCINOMA OF THE ESOPHAGUS AND GASTRIC CARDIA
    BLOT, WJ
    DEVESA, SS
    KNELLER, RW
    FRAUMENI, JF
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (10): : 1287 - 1289
  • [2] Management of localized gastric cancer
    Blum, Mariela A.
    Takashi, Taketa
    Suzuki, Akihiro
    Ajani, Jaffer A.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (03) : 265 - 270
  • [3] RANDOMIZED COMPARISON OF MORBIDITY AFTER D1 AND D2 DISSECTION FOR GASTRIC-CANCER IN 996 DUTCH PATIENTS
    BONENKAMP, JJ
    SONGUN, I
    HERMANS, J
    SASAKO, M
    WELVAART, K
    PLUKKER, JTM
    VANELK, P
    OBERTOP, H
    GOUMA, DJ
    TAAT, CW
    VANLANSCHOT, J
    MEYER, S
    DEGRAAF, PW
    VONMEYENFELDT, MF
    TILANUS, H
    VANDEVELDE, CJH
    [J]. LANCET, 1995, 345 (8952): : 745 - 748
  • [4] Defining Surgical Quality in Gastric Cancer: A RAND/UCLA Appropriateness Study
    Brar, Savtaj
    Law, Calvin
    McLeod, Robin
    Helyer, Lucy
    Swallow, Carol
    Paszat, Lawrence
    Seevaratnam, Rajini
    Cardoso, Roberta
    Dixon, Matthew
    Mahar, Alyson
    Lourenco, Laercio G.
    Yohanathan, Lavanya
    Bocicariu, Alina
    Bekaii-Saab, Tanios
    Chau, Ian
    Church, Neal
    Coit, Daniel
    Crane, Christopher H.
    Earle, Craig
    Mansfield, Paul
    Marcon, Norman
    Miner, Thomas
    Noh, Sung Hoon
    Porter, Geoff
    Posner, Mitchell C.
    Prachand, Vivek
    Sano, Takeshi
    van de Velde, Cornelis
    Wong, Sandra
    Coburn, Natalie
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2013, 217 (02) : 347 - +
  • [5] The Clavien-Dindo Classification of Surgical Complications Five-Year Experience
    Clavien, Pierre A.
    Barkun, Jeffrey
    de Oliveira, Michelle L.
    Vauthey, Jean Nicolas
    Dindo, Daniel
    Schulick, Richard D.
    de Santibanes, Eduardo
    Pekolj, Juan
    Slankamenac, Ksenija
    Bassi, Claudio
    Graf, Rolf
    Vonlanthen, Rene
    Padbury, Robert
    Cameron, John L.
    Makuuchi, Masatoshi
    [J]. ANNALS OF SURGERY, 2009, 250 (02) : 187 - 196
  • [6] COX DR, 1972, J R STAT SOC B, V34, P187
  • [7] Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
    Cunningham, David
    Allum, William H.
    Stenning, Sally P.
    Thompson, Jeremy N.
    Van de Velde, Cornelis J. H.
    Nicolson, Marianne
    Scarffe, J. Howard
    Lofts, Fiona J.
    Falk, Stephen J.
    Iveson, Timothy J.
    Smith, David B.
    Langley, Ruth E.
    Verma, Monica
    Weeden, Simon
    Chua, Yu Jo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) : 11 - 20
  • [8] Postoperative morbidity and mortality after D-1 and D-2 resections for gastric cancer: Preliminary results of the MRC randomised controlled surgical trial
    Cuschieri, A
    Fayers, P
    Fielding, J
    Craven, J
    Bancewicz, J
    Joypaul, V
    Cook, P
    [J]. LANCET, 1996, 347 (9007) : 995 - 999
  • [9] de Melo GM, 2001, ARCH OTOLARYNGOL, V127, P828
  • [10] Edge S.B., 2010, AJCC cancer staging manual, V649